USciences and Franklin BioScience announce a collaboration to help strengthen and enrich education, research, training
and employment opportunities in the maturing multibillion-dollar cannabis sector in
the US.

“This partnership will enrich the healthcare community’s understanding of cannabis
by bringing together USciences’ strength in healthcare research and education with
Franklin BioScience’s expertise and knowledge of developing innovative and trusted,
scientifically supported medical cannabis products,” said Andrew Peterson, PharmD, PhD'09, John Wyeth Dean of Mayes College of Healthcare Business and Policy at USciences.

“We are honored to work with such a respected healthcare visionary like the USciences
to help empower healthcare professionals with the knowledge they need to provide cutting-edge
services,” said Jeremy Kahn, CEO of Franklin BioScience. “Excellence in research, science, and innovation
is core to our mission. We believe that the healthcare community should and must play
a vital role in the cannabis industry's growth and legitimization. We look forward
to helping broaden healthcare providers’ and our partners’ understanding of the cannabis
plant and better educating healthcare professionals on how safe, third-party tested
and high-quality medical cannabis products can be used as a reliable medical alternative
to treat a variety of patient conditions, and look forward to working with more healthcare
leaders and pioneers now and in the future.”

The USciences-Franklin BioScience collaboration will include the development of educational
programming focused on preparing students to understand the cannabis plant and its
medicinal value. It will also provide a valuable research partnership. The organizations
will actively work to develop a host of co-branded and mutually accessible curriculum
and materials -- created with oversight by the USciences experts and faculty with
input harvested from Franklin BioScience’s firsthand expertise researching, working,
and innovating with the cannabis plant -- to help best educate physicians, healthcare
professionals, and other interested parties.

Franklin BioScience will expand its cultivation, manufacturing and dispensary operations,
which span across Colorado and Nevada (two states where both medical and adult-use
cannabis are legal). In the New Year, Franklin BioScience will also begin to serve
patients at multiple dispensaries in Southeastern PA.

In 2017, the North American cannabis marketplace will grow 33 percent to nearly $10
billion. And with California and Canada coming online soon, adult-use markets will
push the 2021 market to over $24 billion, according to Arcview Market Research. The latest Gallup poll also shows growing support for cannabis legalization with
64 percent of Americans now in favor of the measure. To date, the industry has also created over one-hundred thousand well-paying jobs
across the country.

About Franklin BioScienceFranklin BioScience, the manufacturer of Altus products, operates in the legal cannabis sector that is changing lives for the better
by providing patients and consumers with safe access to the highest-quality, consistent
and precise cannabis products. Backed by a team of experts, Ph.D.'s, master cultivators and producers for science and precision, Franklin BioScience’s
companies and brands research, develop and bring to market only the cleanest, safest,
consistent and innovative cannabis products for the health, wellness and lifestyle
marketplaces. The Franklin BioScience team is setting a new standard for best-in-class
operating procedures, quality control, professionalism, testing methodologies and
manufacturing and agricultural practices in the cannabis industry.